Merlin/NF2 regulates SLC7A11/xCT expression and cell viability under glucose deprivation at high cell density in glioblastoma cells

被引:1
作者
Yamaguchi, Itsuki [1 ,2 ]
Katoh, Hironori [2 ]
机构
[1] Kyoto Univ, Grad Sch Biostudies, Lab Mol Neurobiol, Yoshidakonoe Cho,Sakyo Ku, Kyoto 6068501, Japan
[2] Osaka Metropolitan Univ, Grad Sch Sci, Dept Biol Chem, Gakuen Cho,Naka Ku, Sakai, Osaka 5998531, Japan
基金
日本学术振兴会;
关键词
amino acid transport; cell death; cell density; glioblastoma; transcriptional regulation; NF2; TUMOR-SUPPRESSOR; CYSTINE/GLUTAMATE ANTIPORTER; CONTACT INHIBITION; SYSTEM X(C)(-); HIPPO PATHWAY; CANCER; GROWTH; FERROPTOSIS; MECHANISMS; PROTEIN;
D O I
10.1093/jb/mvad105
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The cystine/glutamate transporter SLC7A11/xCT is highly expressed in many cancer cells and plays an important role in antioxidant activity by supplying cysteine for glutathione synthesis. Under glucose-depleted conditions, however, SLC7A11-mediated cystine uptake causes oxidative stress and cell death called disulfidptosis, a new form of cell death. We previously reported that high cell density (HD) promotes lysosomal degradation of SLC7A11 in glioblastoma cells, allowing them to survive under glucose-depleted conditions. In this study, we found that the neurofibromatosis type 2 gene, Merlin/NF2 is a key regulator of SLC7A11 in glioblastoma cells at HD. Deletion of Merlin increased SLC7A11 protein level and cystine uptake at HD, leading to promotion of cell death under glucose deprivation. Furthermore, HD significantly decreased SLC7A11 mRNA level, which was restored by Merlin deletion. This study suggests that Merlin suppresses glucose deprivation-induced cell death by downregulating SLC7A11 expression in glioblastoma cells at HD. Graphical Abstract
引用
收藏
页码:313 / 322
页数:10
相关论文
共 39 条
  • [21] Actin cytoskeleton vulnerability to disulfide stress mediates disulfidptosis
    Liu, Xiaoguang
    Nie, Litong
    Zhang, Yilei
    Yan, Yuelong
    Wang, Chao
    Colic, Medina
    Olszewski, Kellen
    Horbath, Amber
    Chen, Xiong
    Lei, Guang
    Mao, Chao
    Wu, Shiqi
    Zhuang, Li
    Poyurovsky, Masha V.
    James You, M.
    Hart, Traver
    Billadeau, Daniel D.
    Chen, Junjie
    Gan, Boyi
    [J]. NATURE CELL BIOLOGY, 2023, 25 (03) : 404 - +
  • [22] Overexpression of ezrin inactivates NF2 tumor suppressor in glioblastoma
    Morales, Fabiana C.
    Molina, Jennifer R.
    Hayashi, Yuho
    Georgescu, Maria-Magdalena
    [J]. NEURO-ONCOLOGY, 2010, 12 (06) : 528 - 539
  • [23] The NF2 tumor suppressor gene product, merlin, mediates contact inhibition of growth through interactions with CD44
    Morrison, H
    Sherman, LS
    Legg, J
    Banine, F
    Isacke, G
    Haipek, CA
    Gutmann, DH
    Ponta, H
    Herrlich, P
    [J]. GENES & DEVELOPMENT, 2001, 15 (08) : 968 - 980
  • [24] Contact inhibition controls cell survival and proliferation via YAP/TAZ-autophagy axis
    Pavel, Mariana
    Renna, Maurizio
    Park, So Jung
    Menzies, Fiona M.
    Ricketts, Thomas
    Fullgrabe, Jens
    Ashkenazi, Avraham
    Frake, Rebecca A.
    Lombarte, Alejandro Carnicer
    Bento, Carla F.
    Franze, Kristian
    Rubinsztein, David C.
    [J]. NATURE COMMUNICATIONS, 2018, 9
  • [25] Role of Merlin/NF2 inactivation in tumor biology
    Petrilli, A. M.
    Fernandez-Valle, C.
    [J]. ONCOGENE, 2016, 35 (05) : 537 - 548
  • [26] The Hippo pathway kinase Lats2 prevents DNA damage-induced apoptosis through inhibition of the tyrosine kinase c-Abl
    Reuven, N.
    Adler, J.
    Meltser, V.
    Shaul, Y.
    [J]. CELL DEATH AND DIFFERENTIATION, 2013, 20 (10) : 1330 - 1340
  • [27] SLC7A11 expression is associated with seizures and predicts poor survival in patients with malignant glioma
    Robert, Stephanie M.
    Buckingham, Susan C.
    Campbell, Susan L.
    Robel, Stefanie
    Holt, Kenneth T.
    Ogunrinu-Babarinde, Toyin
    Warren, Paula P.
    White, David M.
    Reid, Meredith A.
    Eschbacher, Jenny M.
    Berens, Michael E.
    Lahti, Adrienne C.
    Nabors, Louis B.
    Sontheimer, Harald
    [J]. SCIENCE TRANSLATIONAL MEDICINE, 2015, 7 (289)
  • [28] Sainio M, 1997, J CELL SCI, V110, P2249
  • [29] The glutamate/cystine xCT antiporter antagonizes glutamine metabolism and reduces nutrient flexibility
    Shin, Chun-Shik
    Mishra, Prashant
    Watrous, Jeramie D.
    Carelli, Valerio
    D'Aurelio, Marilena
    Jain, Mohit
    Chan, David C.
    [J]. NATURE COMMUNICATIONS, 2017, 8
  • [30] Ferroptosis turns 10: Emerging mechanisms, physiological functions, and therapeutic applications
    Stockwell, Brent R.
    [J]. CELL, 2022, 185 (14) : 2401 - 2421